These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. II. Processing in epithelial ovarian carcinoma cells in vitro. Omelyanenko V; Gentry C; Kopecková P; Kopecek J Int J Cancer; 1998 Feb; 75(4):600-8. PubMed ID: 9466663 [TBL] [Abstract][Full Text] [Related]
3. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 3. The effect of free and polymer-bound adriamycin on the expression of some genes in the OVCAR-3 human ovarian carcinoma cell line. Kunath K; Kopecková P; Minko T; Kopecek J Eur J Pharm Biopharm; 2000 Jan; 49(1):11-5. PubMed ID: 10613922 [TBL] [Abstract][Full Text] [Related]
4. HPMA copolymer bound adriamycin overcomes MDR1 gene encoded resistance in a human ovarian carcinoma cell line. Minko T; Kopecková P; Pozharov V; Kopecek J J Control Release; 1998 Jul; 54(2):223-33. PubMed ID: 9724909 [TBL] [Abstract][Full Text] [Related]
5. Design of a multivalent galactoside ligand for selective targeting of HPMA copolymer-doxorubicin conjugates to human colon cancer cells. David A; Kopecková P; Minko T; Rubinstein A; Kopecek J Eur J Cancer; 2004 Jan; 40(1):148-57. PubMed ID: 14687799 [TBL] [Abstract][Full Text] [Related]
7. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck. Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the anticancer effect of free and HPMA copolymer-bound adriamycin in human ovarian carcinoma cells. Minko T; Kopecková P; Kopecek J Pharm Res; 1999 Jul; 16(7):986-96. PubMed ID: 10450921 [TBL] [Abstract][Full Text] [Related]
9. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro. Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cytotoxicity in human ovarian carcinoma cells exposed to free Mce6 or HPMA copolymer-Mce6 conjugates. Tijerina M; Kopecková P; Kopecek J Photochem Photobiol; 2003 Jun; 77(6):645-52. PubMed ID: 12870851 [TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of N-(2-hydroxypropyl) methacrylamide copolymer-Mesochlorine e6 and adriamycin conjugates in combination treatments. Shiah JG; Sun Y; Peterson CM; Straight RC; Kopecek J Clin Cancer Res; 2000 Mar; 6(3):1008-15. PubMed ID: 10741728 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of HPMA copolymer-aminopropylgeldanamycin conjugates. Kasuya Y; Lu ZR; Kopecková P; Minko T; Tabibi SE; Kopecek J J Control Release; 2001 Jul; 74(1-3):203-11. PubMed ID: 11489496 [TBL] [Abstract][Full Text] [Related]
13. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro. Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588 [TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to HPMA copolymer-bound adriamycin does not induce multidrug resistance in a human ovarian carcinoma cell line. Minko T; Kopecková P; Kopecek J J Control Release; 1999 May; 59(2):133-48. PubMed ID: 10332049 [TBL] [Abstract][Full Text] [Related]
15. Star structure of antibody-targeted HPMA copolymer-bound doxorubicin: a novel type of polymeric conjugate for targeted drug delivery with potent antitumor effect. Kovár M; Strohalm J; Etrych T; Ulbrich K; Ríhová B Bioconjug Chem; 2002; 13(2):206-15. PubMed ID: 11906257 [TBL] [Abstract][Full Text] [Related]
16. Binding and cytotoxicity of HPMA copolymer conjugates to lymphocytes mediated by receptor-binding epitopes. Tang A; Kopeiková P; Kopeckevá J Pharm Res; 2003 Mar; 20(3):360-7. PubMed ID: 12669954 [TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cells. Hongrapipat J; Kopecková P; Liu J; Prakongpan S; Kopecek J Mol Pharm; 2008; 5(5):696-709. PubMed ID: 18729468 [TBL] [Abstract][Full Text] [Related]
18. Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates. Fowers KD; Kopeček J Macromol Biosci; 2012 Apr; 12(4):502-14. PubMed ID: 22278817 [TBL] [Abstract][Full Text] [Related]
19. A possibility to overcome P-glycoprotein (PGP)-mediated multidrug resistance by antibody-targeted drugs conjugated to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer carrier. St'astný M; Strohalm J; Plocová D; Ulbrich K; Ríhová B Eur J Cancer; 1999 Mar; 35(3):459-66. PubMed ID: 10448300 [TBL] [Abstract][Full Text] [Related]
20. Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts. Shiah JJ; Sun Y; Peterson CM; Kopecek J J Control Release; 1999 Aug; 61(1-2):145-57. PubMed ID: 10469911 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]